Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuraminidase (NA) is a surface glycoprotein enzyme found on the influenza A virus, including subtype N1. It plays a critical role in the viral life cycle by cleaving sialic acid residues from glycoproteins and glycolipids on host cell surfaces, facilitating the release of newly formed viral particles and their spread to infect additional cells. NA exists as a homotetramer with a catalytic head domain containing key residues involved in sialic acid binding and cleavage. Inhibition of NA is a therapeutic strategy for treating influenza infections.
Inhibition of neuraminidase enzymatic activity, preventing the release of new virions from infected cells.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuraminidase protein of Influenza A virus subtype N1 (NA).